- Home
- GDTC vs STEC Comparison
GDTC vs STEC Comparison
Compare GDTC & STEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- STEC
- Stock Information
- Founded
- GDTC 2018
- STEC 2006
- Country
- GDTC Singapore
- STEC Hong Kong
- Employees
- GDTC N/A
- STEC N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- STEC
- Sector
- GDTC Health Care
- STEC
- Exchange
- GDTC Nasdaq
- STEC NYSE
- Market Cap
- GDTC 21.5M
- STEC 63.8M
- IPO Year
- GDTC 2023
- STEC 2021
- Fundamental
- Price
- GDTC $1.94
- STEC $0.72
- Analyst Decision
- GDTC Buy
- STEC
- Analyst Count
- GDTC 1
- STEC 0
- Target Price
- GDTC $5.00
- STEC N/A
- AVG Volume (30 Days)
- GDTC 18.1K
- STEC 12.8K
- Earning Date
- GDTC 01-01-0001
- STEC 08-05-2025
- Dividend Yield
- GDTC N/A
- STEC N/A
- EPS Growth
- GDTC N/A
- STEC N/A
- EPS
- GDTC N/A
- STEC N/A
- Revenue
- GDTC $368,838.00
- STEC $10,672,000.00
- Revenue This Year
- GDTC $5.37
- STEC $9,392.20
- Revenue Next Year
- GDTC N/A
- STEC N/A
- P/E Ratio
- GDTC N/A
- STEC N/A
- Revenue Growth
- GDTC N/A
- STEC N/A
- 52 Week Low
- GDTC $1.20
- STEC $0.20
- 52 Week High
- GDTC $4.05
- STEC $3.25
- Technical
- Relative Strength Index (RSI)
- GDTC 39.79
- STEC 38.03
- Support Level
- GDTC $1.85
- STEC $0.70
- Resistance Level
- GDTC $2.26
- STEC $0.80
- Average True Range (ATR)
- GDTC 0.11
- STEC 0.08
- MACD
- GDTC -0.02
- STEC 0.00
- Stochastic Oscillator
- GDTC 31.67
- STEC 34.03
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About STEC SANTECH HOLDINGS LIMITED
Santech Holdings Ltd is a technology company focusing on exploring various opportunities in consumer technology, consumer healthcare and enterprise technology. It has two revenue segments Wealth management service and Asset management service. Key revenue is generated from Wealth management service.